This review article discusses the concepts of a tumor microenvironment and a gut microbiome and their effects on responses to checkpoint inhibitors (CPIs). It also reviews recent research investigating these 3 topics, and how it can be applied to using CPIs in prostate cancer.
|Original language||English (US)|
|Journal||ONCOLOGY (United States)|
|State||Published - Mar 19 2020|
ASJC Scopus subject areas
- Cancer Research